Histiocyte Society Explained
The Histiocyte Society is an international network of people that co-ordinate studies of the histiocytoses, which it has divided into Langerhans cell histiocytosis (class I) (previously known as Hand–Schüller–Christian disease and histocytosis-X), non-Langerhans cell histiocytoses (class II), and malignant histiocytosis (class III).[1] [2] [3] [4] They provided the criteria to definitively diagnose Langerhans cell histiocytosis.[5]
Notes and References
- Web site: Tebbi. Cameron K.. 16 September 2020. Kanwar. Vikramjit S. What is the Histiocyte Society classification of histiocytosis syndromes?. 4 December 2020. Medscape.
- Book: H. A. Harfi. Textbook of Clinical Pediatrics. F. B. Stapleton. H. Nazer. Springer Science & Business Media. 2012. 978-3-642-02202-9. 3215.
- Book: Chang. Karen L.. https://books.google.com/books?id=cR_kOJoN7sYC&pg=PA382. Rare Hematological Malignancies. Snyder. David S.. Springer Science & Business Media. 2007. 978-0-387-73743-0. Stephen M. Ansell. 383. 17. Langerhans Cell Histiocytosis.
- Satter. Elizabeth K.. High. Whitney A.. May 2008. Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society. Pediatric Dermatology. 25. 3. 291–295. 10.1111/j.1525-1470.2008.00669.x. 1525-1470. 18577030. 20024618.
- Book: Ajithkumar. Thankamma V. https://books.google.com/books?id=etn4ofHeOacC&pg=PA523. Oxford Desk Reference: Oncology. Barrett. Ann. Hatcher. Helen. Cook. Natalie. Oxford University Press. 2011. 978-0-19-923563-6. 523. 4. Site specific cancer management.